HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Escin attenuates acute lung injury induced by endotoxin in mice.

Abstract
Endotoxin causes multiple organ dysfunctions, including acute lung injury (ALI). The current therapeutic strategies for endotoxemia are designed to neutralize one or more of the inflammatory mediators. Accumulating experimental evidence suggests that escin exerts anti-inflammatory and anti-edematous effects. The aim of this study was to evaluate the effect of escin on ALI induced by endotoxin in mice. ALI was induced by injection of lipopolysaccharide (LPS) intravenously. The mice were given dexamethasone or escin before injection of LPS. The mortality rate was recorded. Tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β) and nitric oxide (NO) were measured. Pulmonary superoxide dismutase (SOD), glutathione peroxidase (GPx) activity, glutathione (GSH), malondialdehyde (MDA) contents, and myeloperoxidase (MPO) activity were also determined. The expression of glucocorticoid receptor (GR) level was detected by Western blotting. Pretreatment with escin could decrease the mortality rate, attenuate lung injury resulted from LPS, down-regulate the level of the inflammation mediators, including NO, TNF-α, and IL-1β, enhance the endogenous antioxidant capacity, and up-regulating the GR expression in lung. The results suggest that escin may have potent protective effect on the LPS-induced ALI by inhibiting of the inflammatory response, and its mechanism involves in up-regulating the GR and enhancing the endogenous antioxidant capacity.
AuthorsWenyu Xin, Leiming Zhang, Huaying Fan, Na Jiang, Tian Wang, Fenghua Fu
JournalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci) Vol. 42 Issue 1-2 Pg. 73-80 (Jan 18 2011) ISSN: 1879-0720 [Electronic] Netherlands
PMID21040784 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Interleukin-1beta
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • lipopolysaccharide, E coli O55-B5
  • Nitric Oxide
  • Escin
  • Peroxidase
  • Glutathione Peroxidase
  • Superoxide Dismutase
Topics
  • Acute Lung Injury (chemically induced, enzymology, immunology, pathology, prevention & control)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Antioxidants (metabolism)
  • Blotting, Western
  • Escin (administration & dosage, therapeutic use)
  • Glutathione Peroxidase (metabolism)
  • Interleukin-1beta (immunology)
  • Lipopolysaccharides (toxicity)
  • Lung (drug effects, enzymology, immunology, pathology)
  • Male
  • Mice
  • Nitric Oxide (biosynthesis)
  • Peroxidase (metabolism)
  • Superoxide Dismutase (metabolism)
  • Survival Analysis
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: